High dose benzodiazepine dependence: Description of 29 patients treated with flumazenil infusion and stabilised with clonazepam

@article{Quaglio2012HighDB,
  title={High dose benzodiazepine dependence: Description of 29 patients treated with flumazenil infusion and stabilised with clonazepam},
  author={Gianluca Quaglio and Cristian Pattaro and Gilberto Gerra and Sophie Mathewson and Paul Verbanck and Don Des Jarlais and Fabio Lugoboni},
  journal={Psychiatry Research},
  year={2012},
  volume={198},
  pages={457-462}
}

Figures and Tables from this paper

Slow subcutaneous infusion of flumazenil for the treatment of long-term, high-dose benzodiazepine users: a review of 214 cases
TLDR
The data support FLU-SSI as a possible efficient strategy for the treatment of patients with long-term, high-dose benzodiazepine addiction, and could become a routine therapy as long as the necessary further studies on dose, duration of infusion and safety issues are carried out.
Benzodiazepine dependence and its treatment with low dose flumazenil
TLDR
Preliminary in vitro water bath and in vivo biocompatibility data in sheep show that such an implant is feasible and so is likely to be used in clinical trials in the near future, and could be capable of managing both acute and longer term benzodiazepine withdrawal sequelae.
A Case Report of Clonazepam Dependence
TLDR
It is the first case report showing utilization of therapeutic drug monitoring during withdrawal period in the patient with extreme toleration to severe benzodiazepine dependence, and gradual withdrawal with monitoring of its serum levels and increase of gabapentin dose were used to minimize physical signs and symptoms of clonazepam withdrawal.
Low risk of seizures with slow flumazenil infusion and routine anticonvulsant prophylaxis for high-dose benzodiazepine dependence
TLDR
Evaluated the occurrence of seizures in 450 consecutive high-dose BZD dependence patients admitted to the authors' unit from April 2012 to April 2016 for detoxification with low-dose slow subcutaneous infusion of flumazenil associated with routine anticonvulsant prophylaxis to indicate that, when routinely associated with AEDs proplylaxis, low- dose slow sub cutaneous flumazerous infusion represents a safe procedure, with low risk of seizure occurrence.
Flumazenil in treatment benzodiazepine withdrawal syndrome: Case report
TLDR
Fumazenil protocol is an effi cient method in the treatment of the benzodiazepine withdrawal syndrome and leads to a reduction in symptoms of abstinence syndrome and anxiety in the longer term after treatment, thereby acting favorably to the adherence and remission.
Addiction of High Dose of Benzodiazepine: Verona Detox Approach With Flumazenil
TLDR
To this day, the largest database of FLU detoxification was published by the Verona Detox group, showing how this treatment is safe, with very little side effects even in patients with significant medical comorbidities.
Withdrawing Benzodiazepines in Patients With Anxiety Disorders
TLDR
It is concluded that little evidence exists outside the usual principles of drug withdrawal but there are some promising leads.
Pharmacological uses of flumazenil in benzodiazepine use disorders: a systematic review of limited data
TLDR
Although flumazenil shows promising efficacy in the management of benzodiazepine use disorders and withdrawal, more randomized control trials are required before a definitive recommendation can be made around its use.
Quality of life in a cohort of high-dose benzodiazepine dependent patients.
...
1
2
3
4
...

References

SHOWING 1-10 OF 60 REFERENCES
The role of flumazenil in the treatment of benzodiazepine dependence: physiological and psychological profiles
TLDR
Low-dose flumazenil infusion appears to be a safe and effective treatment resulting in withdrawal symptoms of lesser severity than any other cessation method currently available.
Effects of flumazenil in the treatment of benzodiazepine withdrawal – a double-blind pilot study
TLDR
There was an overall difference between patients and controls, with patients scoring higher on negative and somatic items and lower on positive psychological items, and flumazenil reduced symptoms thought to be important in withdrawal in patients treated for benzodiazepine dependency.
Intravenous flumazenil versus oxazepam tapering in the treatment of benzodiazepine withdrawal: a randomized, placebo‐controlled study
TLDR
The effectiveness of FLU may reflect its capacity to upregulate BZD receptors and to reverse the uncoupling between the recognition sites of BzD and GABA, on the GABA A macromolecular complex, that has been reported in tolerant subjects.
Long-term therapeutic use of benzodiazepines. I. Effects of abrupt discontinuation.
TLDR
A short half-life and higher daily doses were associated with greater withdrawal severity, as were personality traits, such as dependency and neuroticism, less education and higher baseline levels of anxious and depressive symptoms.
A controlled study of flumazenil-precipitated withdrawal in chronic low-dose benzodiazepine users
TLDR
This study clearly demonstrates that flumazenil can precipitate symptoms commonly associated with benzodiazepine withdrawal in chronic low-dose benzODiazepine users.
Long-term diazepam therapy and clinical outcome.
TLDR
It is indicated that a significant number of patients benefit from prolonged diazepam treatment and that tolerance to the anxiolytic effect of diazepAM does not develop during a 22-week study period.
Intravenous flumazenil infusion to treat benzodiazepine dependence should be performed in the inpatient clinical setting for high risk of seizure
TLDR
Flu-I appears to be a highly effective treatment resulting in withdrawal discomfort of lesser severity than any other treatment cessation currently available but, in the authors' opinion, FLU-I is not so safe as suggested by Hood et al.
Dependence on zolpidem: two case reports of detoxification with flumazenil infusion.
TLDR
This work describes two cases of zolpidem dependence that were detoxified by the use of flumazenil infusion and may represent an alternative to detoxification treatment by employing a tapering approach, or by replacement therapy with BDZs with a long half-life, particularly where patients are hard to treat or have low compliance to treatment.
Issues in the clinical use of benzodiazepines: potency, withdrawal, and rebound.
  • G. Chouinard
  • Psychology, Medicine
    The Journal of clinical psychiatry
  • 2004
TLDR
Although as a class benzodiazepines act rapidly and are well tolerated, their use presents clinical issues such as dependence, rebound anxiety, memory impairment, and discontinuation syndrome.
The diagnosis and management of benzodiazepine dependence
  • H. Ashton
  • Medicine, Psychology
    Current opinion in psychiatry
  • 2005
TLDR
Benzodiazepine dependence could be prevented by adherence to recommendations for short-term prescribing (2–4 weeks only when possible), and withdrawal from dependent patients is feasible and need not be traumatic if judiciously, and often individually, managed.
...
1
2
3
4
5
...